Pyogenic granuloma/Peripheral giant-cell granuloma associated with implants

Introduction: pyogenic granuloma (PG) and peripheral giant-cell granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG...

Descripción completa

Detalles Bibliográficos
Autores: Jané Salas, Enric, Alburquerque, Rui, Font i Muñoz, Aura, González Navarro, Beatriz, Estrugo Devesa, Albert, López López, José, 1958-
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/126889
Acceso en línea:https://hdl.handle.net/2445/126889
Access Level:acceso abierto
Palabra clave:Implants dentals
Inflamació
Pròtesis dentals
Ressenyes sistemàtiques (Investigació mèdica)
Dental implants
Inflammation
Dental prosthesis
Systematic reviews (Medical research)
Descripción
Sumario:Introduction: pyogenic granuloma (PG) and peripheral giant-cell granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed. Methods: to collect relevant information about previous treatments for PG and PGCG involving implants we carried out electronic searches of publications with the key words 'granuloma', 'oral', and 'implants' from the last 15 years on the databases Pubmed, National Library of Medicine's Medline, Scielo, Scopus, and Cochrane Library. Results: from the electronic search 16 case reports were found showing excision and curettage as the main successful treatment. As no clinical trials or observational studies were identified the authors agreed to present results from a review perspective. Conclusion: this is the largest analysis of PG and PGCG associated with implants published to date. Our review would suggest that PGCG associated with implants appears to have a more aggressive nature; however the level of evidence is very limited. Further cohort studies with representative sample sizes and standard outcome measures are necessary for better understanding of these conditions.